Annual Operating Expenses
$136.29 M
+$14.15 M+11.59%
31 December 2023
Summary:
Cara Therapeutics annual total operating expenses is currently $136.29 million, with the most recent change of +$14.15 million (+11.59%) on 31 December 2023. During the last 3 years, it has risen by +$6.59 million (+5.08%). CARA annual operating expenses is now at all-time high.CARA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$7.84 M
-$7.88 M-50.13%
30 September 2024
Summary:
Cara Therapeutics quarterly total operating expenses is currently $7.84 million, with the most recent change of -$7.88 million (-50.13%) on 30 September 2024. Over the past year, it has dropped by -$24.37 million (-75.67%). CARA quarterly operating expenses is now -80.51% below its all-time high of $40.22 million, reached on 30 September 2019.CARA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.6% | -75.7% |
| 3 y3 years | +5.1% | -63.4% |
| 5 y5 years | +50.0% | -80.5% |
CARA Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +21.6% | -79.3% | at low |
| 5 y | 5 years | at high | +50.0% | -80.5% | at low |
| alltime | all time | at high | +1735.3% | -80.5% | +419.0% |
Cara Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.84 M(-50.1%) |
| June 2024 | - | $15.72 M(-45.4%) |
| Mar 2024 | - | $28.78 M(-17.8%) |
| Dec 2023 | $136.29 M(+11.6%) | $35.00 M(+8.7%) |
| Sept 2023 | - | $32.21 M(-14.9%) |
| June 2023 | - | $37.85 M(+21.2%) |
| Mar 2023 | - | $31.23 M(-3.7%) |
| Dec 2022 | $122.14 M(+8.9%) | $32.44 M(+2.6%) |
| Sept 2022 | - | $31.60 M(+15.0%) |
| June 2022 | - | $27.48 M(-10.3%) |
| Mar 2022 | - | $30.62 M(-10.8%) |
| Dec 2021 | $112.11 M(-13.6%) | $34.34 M(+60.5%) |
| Sept 2021 | - | $21.40 M(-30.7%) |
| June 2021 | - | $30.88 M(+21.1%) |
| Mar 2021 | - | $25.50 M(-24.6%) |
| Dec 2020 | $129.70 M(-1.4%) | $33.80 M(+28.6%) |
| Sept 2020 | - | $26.29 M(-16.6%) |
| June 2020 | - | $31.52 M(-17.3%) |
| Mar 2020 | - | $38.09 M(+10.5%) |
| Dec 2019 | $131.56 M(+44.8%) | $34.48 M(-14.3%) |
| Sept 2019 | - | $40.22 M(+37.0%) |
| June 2019 | - | $29.35 M(+6.7%) |
| Mar 2019 | - | $27.52 M(+0.0%) |
| Dec 2018 | $90.85 M | $27.51 M(+7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $25.53 M(+23.4%) |
| June 2018 | - | $20.69 M(+20.8%) |
| Mar 2018 | - | $17.12 M(+17.5%) |
| Dec 2017 | $60.40 M(+3.3%) | $14.57 M(+12.5%) |
| Sept 2017 | - | $12.96 M(+34.5%) |
| June 2017 | - | $9.63 M(-58.5%) |
| Mar 2017 | - | $23.24 M(+4.1%) |
| Dec 2016 | $58.49 M(+101.7%) | $22.32 M(+89.5%) |
| Sept 2016 | - | $11.77 M(-12.2%) |
| June 2016 | - | $13.40 M(+21.9%) |
| Mar 2016 | - | $10.99 M(+13.0%) |
| Dec 2015 | $28.99 M(+36.4%) | $9.73 M(+30.6%) |
| Sept 2015 | - | $7.45 M(+12.8%) |
| June 2015 | - | $6.61 M(+26.9%) |
| Mar 2015 | - | $5.21 M(-0.8%) |
| Dec 2014 | $21.25 M(+74.2%) | $5.25 M(-32.1%) |
| Sept 2014 | - | $7.73 M(+65.4%) |
| June 2014 | - | $4.67 M(+29.8%) |
| Mar 2014 | - | $3.60 M(+16.9%) |
| Dec 2013 | $12.20 M(+64.3%) | $3.08 M(-32.5%) |
| Sept 2013 | - | $4.56 M(+49.3%) |
| June 2013 | - | $3.05 M(+102.3%) |
| Mar 2013 | - | $1.51 M(-14.6%) |
| Dec 2012 | $7.43 M(-22.4%) | $1.77 M |
| Dec 2011 | $9.57 M | - |
FAQ
- What is Cara Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Cara Therapeutics?
- What is Cara Therapeutics annual operating expenses year-on-year change?
- What is Cara Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Cara Therapeutics?
- What is Cara Therapeutics quarterly operating expenses year-on-year change?
What is Cara Therapeutics annual total operating expenses?
The current annual operating expenses of CARA is $136.29 M
What is the all time high annual operating expenses for Cara Therapeutics?
Cara Therapeutics all-time high annual total operating expenses is $136.29 M
What is Cara Therapeutics annual operating expenses year-on-year change?
Over the past year, CARA annual total operating expenses has changed by +$14.15 M (+11.59%)
What is Cara Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of CARA is $7.84 M
What is the all time high quarterly operating expenses for Cara Therapeutics?
Cara Therapeutics all-time high quarterly total operating expenses is $40.22 M
What is Cara Therapeutics quarterly operating expenses year-on-year change?
Over the past year, CARA quarterly total operating expenses has changed by -$24.37 M (-75.67%)